Author

rachelsachs

  • Intellectual Property

    Akamai v. Limelight: Implications for Medical Method Patents (Redux)

    By Rachel Sachs Yesterday, the Court of Appeals for the Federal Circuit issued a unanimous en banc ruling in Akamai v. Limelight, altering the reach of patent liability for induced infringement of a method claim…

    Akamai v. Limelight: Implications for Medical Method Patents (Redux)

    By

    rachelsachs

  • Health Law Policy

    House Passes 21st Century Cures Act, Including a New NIH Innovation Prize Fund

    By Rachel Sachs This morning, the House of Representatives passed the 21st Century Cures Act by a vote of 344-77, achieving a truly bipartisan result in a difficult political environment.  (I’ve blogged about the Act…

    House Passes 21st Century Cures Act, Including a New NIH Innovation Prize Fund

    By

    rachelsachs

  • Affordable Care Act

    The ACA Survives — But With A Note Of Caution For The Future?

    By Rachel Sachs Academic Fellow Rachel Sachs has a new piece up at the Health Affairs Blog discussing the Supreme Court’s decision in King v. Burwell. From the piece:  Chief Justice Roberts has once again saved a core provision…

    The ACA Survives — But With A Note Of Caution For The Future?

    By

    rachelsachs

  • Affordable Care Act

    Happy about the Supreme Court’s ACA decision? Thank a law professor

    By Rachel Sachs [Originally published on The Conversation]. The core of the Affordable Care Act (ACA) has now survived its second trip to the Supreme Court. Chief Justice John Roberts wrote for the majority in King…

    Happy about the Supreme Court’s ACA decision? Thank a law professor

    By

    rachelsachs

  • Affordable Care Act

    How law professors helped the Supreme Court understand the Affordable Care Act

    By Rachel Sachs [Originally published on The Conversation]. In March, the Supreme Court heard oral arguments in King v Burwell, a case that could broadly impact the functioning of the Affordable Care Act (ACA). The central question in King…

    How law professors helped the Supreme Court understand the Affordable Care Act

    By

    rachelsachs

  • Biotechnology

    Ariosa v. Sequenom Invalidates the Non-Invasive Prenatal Testing Patent

    By Rachel Sachs On Friday, the Court of Appeals for the Federal Circuit affirmed the district court’s judgment of invalidity of several claims in Sequenom’s diagnostic method patent on the grounds that they were not…

    Ariosa v. Sequenom Invalidates the Non-Invasive Prenatal Testing Patent

    By

    rachelsachs

  • FDA

    New Discussion Draft of 21st Century Cures Act Released (Again)

    By Rachel Sachs Earlier today, the House Energy and Commerce Committee released the most recent draft of the 21st Century Cures Act, in time for it to be marked up by the Health Subcommittee tomorrow.…

    New Discussion Draft of 21st Century Cures Act Released (Again)

    By

    rachelsachs

  • FDA

    New Discussion Draft of 21st Century Cures Act Released

    By Rachel Sachs Yesterday, a new discussion draft of the 21st Century Cures Act was released, just in time for today’s hearing on the draft before the House Energy and Commerce Committee.  At just 200…

    New Discussion Draft of 21st Century Cures Act Released

    By

    rachelsachs

  • Affordable Care Act

    Academic Fellow Rachel Sachs in the SCOTUSblog, on King v. Burwell

    Academic Fellow Rachel Sachs was quoted today in the SCOTUSblog: Wednesday’s oral arguments in King v. Burwell, the challenge to the availability of tax subsidies for individuals who purchase their health insurance on a marketplace created…

    Academic Fellow Rachel Sachs in the SCOTUSblog, on King v. Burwell

    By

    rachelsachs